The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance
Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies
The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy
Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days
The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts
The company aims to meet the increased demand for approved media to maintain virus viability from sample collection to the lab
The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens
Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry
The partnership aims to expand existing Monocyte Distribution Width (MDW) hematology-based biomarker to potentially aid in the rapid detection of MIS-C
The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses
Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19
Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results
The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients
Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication
Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies
Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein
The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease
EpiMOGRIFY supports the development of scalable off-the-shelf cell therapies for diseases with a high unmet clinical need
Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season
The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients
The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts
Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test
Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions
Researchers have made a significant COVID-19 drug target discovery using Thermo Fisher Scientific CryoEM technology
